Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NUVL
#912
Nuvalent, Inc. Class A Common Stock
101.950
0
-0.51%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.51%
Monthly Change
-3.57%
6 month change
+7.37%
Year Change
+7.37%
Previous Close
102.470
0
Open
101.950
0
Bid
Ask
Low
101.950
0
High
101.950
0
Volume
98
Markets
US Stock Market
Healthcare
NUVL
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug
Drugmakers turn to AI to speed trials, regulatory submissions
Nuvalent Inc stock hits 52-week high at 112.89 USD
FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment
Nuvalent (NUVL) chief legal officer Miller sells $676k in stock
Nuvalent CSO Pelish sells shares worth $501,752
Nuvalent (NUVL) chief development officer sells $721k in stock
What's Going On With Royalty Pharma Stock Wednesday? - Royalty Pharma (NASDAQ:RPRX)
3 Biotech Stocks With Major 2026 Catalysts
UBS reiterates Buy rating on Nuvalent stock, citing Royalty Pharma deal
Nuvalent appoints Ron Squarer to board of directors
Nuvalent: Deerfield funds sell $70.8m in NUVL stock